Single-dose Quadrivalent Influenza Vaccine — Competitive Intelligence Brief

Single-dose Quadrivalent Influenza Vaccine (Single-dose Quadrivalent Influenza Vaccine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Influenza vaccine. Area: Immunology.

phase 3 Influenza vaccine Immunology Biologic

Target snapshot

Single-dose Quadrivalent Influenza Vaccine (Single-dose Quadrivalent Influenza Vaccine) — Sanofi Pasteur, a Sanofi Company. This vaccine induces an immune response against four different influenza viruses.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Single-dose Quadrivalent Influenza Vaccine TARGET	Single-dose Quadrivalent Influenza Vaccine	Sanofi Pasteur, a Sanofi Company	phase 3	Influenza vaccine
Influenza Fluzone vaccine	Influenza Fluzone vaccine	La Jolla Institute for Immunology	marketed	inactivated influenza vaccine
SD Fluzone Vaccine	SD Fluzone Vaccine	Insight Therapeutics, LLC	marketed	inactivated influenza vaccine
Seasonal trivalent influenza vaccine, Fluarix	Seasonal trivalent influenza vaccine, Fluarix	Center for Disease Prevention and Control of Beijing Military Region	marketed	inactivated influenza vaccine
CSL Influenza Vaccine	CSL Influenza Vaccine	Seqirus	marketed	inactivated influenza vaccine
CSL Limited Influenza Virus Vaccine	CSL Limited Influenza Virus Vaccine	Seqirus	marketed	inactivated influenza vaccine
SD-QIV	SD-QIV	McGill University Health Centre/Research Institute of the McGill University Health Centre	marketed	Inactivated influenza vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Influenza vaccine class)

1. GlaxoSmithKline · 8 drugs in this class
2. Sanofi Pasteur, a Sanofi Company · 2 drugs in this class
3. Seqirus · 2 drugs in this class
4. MedImmune LLC · 1 drug in this class
5. AstraZeneca · 1 drug in this class
6. Novartis · 1 drug in this class
7. Protein Sciences Corporation · 1 drug in this class
8. ModernaTX, Inc. · 1 drug in this class
9. Institute of Vaccines and Medical Biologicals, Vietnam · 1 drug in this class
10. Janssen Vaccines & Prevention B.V. · 1 drug in this class